Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $10.80 Consensus PT from Analysts
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has earned a consensus recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have updated their coverage on the stock in the last […]
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has earned a consensus recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have updated their coverage on the stock in the last […]